Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 747-750

  Wenisch, Christoph ^a,b,c   Linnau, Ken F ^a,b   Looaresuwan, Sornchai ^a,b   Rumpold, Helmut ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CILIARY NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRAIN MALARIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; KIDNEY FAILURE; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0033396305     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314630     Document Type: Article

References (15)

1. 1. Urquhart AD. Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falicparum malaria. Clin Infect Dis 1994;19:117-31.
2. 2. Hibi M, Nakajima K, Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 1996;74:1-12.
3. 3. Metcalf D. The leukemia inhibitory factor (LIF). Int J Cell Cloning 1991; 9:95-108.
4. 4. Villers D, Dao T, Nguyen JM, et al. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor pathogens. J Infect Dis 1995;171:232-6.
5. 5. Ip NY, Yancopoulos GD. The neutrophils and CNTF: two families of collaborative neutrophic factors. Annu Rev Neurosci 1996;19:491-515.
6. 6. Richardson PM. Ciliary neurotrophic factor: a review. Pharmacol Ther 1994;63:187-98.
7. 7. Bazan JF. Haemopoietic receptors and helical cytokines. Immunol Today 1990;11:350-4.
8. 8. Ip NY, Nye SH, Boulton TG, et al. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992;69:1121-32.
9. 9. World Health Organization. Division of Control of Tropical Diseases. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84(suppl): 1-65.
10. 10. Kern P, Hemmer CJ, Galatti H, et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 1992;166:930-4.
11. 11. Prada J, Prager C, Neifer S, Bienzle U, Kremsner PG. Production of interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens is enhanced by pentoxifylline, and tumor necrosis factor secretion is reduced. Infect Immun 1993;61:2737-40.
12. 12. Kragsbjerg P, Holmberg H, Vikerfors T. Dynamics of blood cytokines concentrations in patients with bacteremic infections. Scand J Infect Dis 1996;28:391-6.
13. 13. Deloron P, Dumont N, Nyongabo, et al. Immunologic and biochemical alterations in severe falciparum malaria: relation to neurological symptoms and outcome. Clin Infect Dis 1994;19:480-5.
14. 14. Aikawa M, Iseki M, Barnwell JW, et al. The pathology of human cerebral malaria. Am J Trop Med Hyg 1990;43(suppl):30-7.
15. 15. Varney NR, Roberts RJ, Springer JA, et al. Neuropsychiatric sequclae of cerebral malaria in Vietnam veterans. J Nerv Ment Dis 1997;185:695-703.